Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03838536 · ClinicalTrials.gov registry record · NA

Synergistic Activity of Human Milk Nutrients and Infant Cognition

A NA study of Breastfeeding, Exclusive, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT03838536: Recruiting NA study of Breastfeeding, Exclusive, sponsored by University of North Carolina, Chapel Hill.

NCT03838536 is a NA study of Breastfeeding, Exclusive that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 84 participants, below the 475-participant average among 8 other Breastfeeding, Exclusive trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03838536, a NA study of Breastfeeding, Exclusive, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. There will be 84 breastfeeding dyads, 3 months postnatal. Mothers will be randomized to a whole egg or egg white (due to lack of an appropriate control food). Initial diet intake will be screened using the NDSR. Participants will come to the lab 3 times across 3 months (age 3 months, 4.5 months, and 6 months). Milk, saliva, and plasma will be collected from the mother, while saliva and plasma (heel stick) are collected from the infant. Diet data will be collected at each visit. The infant will complete a recognition memory test using electrophysiology at 6 months as well as the Bayley Scales of Infant Development at 4.5 months. The mother will complete a temperament questionnaire at 3 months and 6 months.

Primary Outcome

The difference in microvolts between the negative deflection to novel pictures and the negative deflection to familiar pictures at approximately 100-400ms after the pictures come on the screen will be measured in an event-related potentials (ERP) paradigm. The investigators hypothesize that the whole egg group will have better memory for the familiar pictures than the egg white group.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whole Egg Powder
  • DIETARY_SUPPLEMENT Egg White Powder

Study Locations (1)

North Carolina

  • Nutrition Research Institute - Kannapolis

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2019-02-05
Est. Completion 2026-03
Phase NA

What NCT03838536 shows while recruiting

NCT03838536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 475-participant average among 8 other Breastfeeding, Exclusive trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Breastfeeding, Exclusive appearing as the primary indexed condition, and to 2 interventions - of which Whole Egg Powder is the first listed.

NCT03838536 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03838536 about?

NCT03838536 is a clinical study titled "Synergistic Activity of Human Milk Nutrients and Infant Cognition". Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. There will be 84 breastfeeding dyads, 3 months postnatal. Mothers will be randomized to a whole egg or egg white (due to lack of an appropriat...

What is the current status of trial NCT03838536?

This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2019-02-05. Estimated completion is 2026-03.

What conditions does trial NCT03838536 study?

This clinical trial studies the following conditions: Breastfeeding, Exclusive.

What interventions are being tested in trial NCT03838536?

The interventions under investigation include: Whole Egg Powder (DIETARY_SUPPLEMENT), Egg White Powder (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03838536?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03838536 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breastfeeding, Exclusive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03838536's enrollment target sits among peer trials

84 6th of 8 higher than 3 of 8 other Breastfeeding, Exclusive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breastfeeding, Exclusive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

  • NCT04245748 · 84 participants · Phase 4

    Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03838536, the US trial registry maintained by the National Library of Medicine. NCT03838536 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.